期刊文献+

胺碘酮治疗充血性心力衰竭合并室性心律失常45例临床观察

暂未订购
导出
摘要 目的:观察胺碘酮治疗充血性心力衰竭(CHF)合并室性心律失常(VA)的疗效及安全性。方法:对充血性心力衰竭合并室性心律失常患者45例,在常规抗心力衰竭治疗的基础上,采用胺碘酮早期静脉与口服同时给药,静脉与口服并用3天后,口服开始起效时,停用静脉胺碘酮,完成从静脉到口服的平稳过渡,4周后通过治疗前后24小时动态心电图检查结果及NYHA心功能分级确定疗效。结论:胺碘酮治疗充血性心力衰竭合并室性心律失常总有效率达84.4%,不良反应少,疗效肯定,是首选抗心律失常药。
作者 李生奇
出处 《中国社区医师(医学专业)》 2009年第9期10-10,共1页
  • 相关文献

参考文献3

二级参考文献8

  • 1Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 2Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 3Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
  • 4The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
  • 5Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
  • 6Khan IA.Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J ,2004,25:1 274
  • 7Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
  • 8抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:789

共引文献520

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部